Get started
Author

Jéssica Castillo-Villalba

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
2019 · Sara Gil-Perotin, Jessica Castillo-Villalba, et al. · Frontiers in Neurology · 80
PDF
Potential Role of CHI3L1+ Astrocytes in Progression in MS
2021 · Laura Cubas-Núñez, Sara Gil-Perotín, et al. · Neurology Neuroimmunology & Neuroinflammation · 58
PDF
CSF chitinase 3-like-1 association with disability of primary progressive MS
2020 · Francisco Pérez-Miralles, Daniel Prefasi, et al. · Neurology Neuroimmunology & Neuroinflammation · 39
PDF
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis
2022 · María Muñoz-San Martín, Imma Gómez, et al. · Neurology Neuroimmunology & Neuroinflammation · 26
PDF
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
2022 · Jéssica Castillo-Villalba, Sara Gil-Perotín, et al. · Frontiers in Immunology · 26
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
2022 · Carmen Alcalá, Carlos Quintanilla-Bordás, et al. · Journal of Neurology · 25
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
2022 · Carlos Quintanilla-Bordás, Francisco Gascón-Gimenez, et al. · Frontiers in Neurology · 16
PDF
Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients
2024 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Multiple Sclerosis and Related Disorders · 10
Renal function’s impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis
2024 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Neurological Sciences · 8
Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm
2023 · Jordi Tortosa-Carreres, Anna Quiroga-Varela, et al. · Multiple Sclerosis and Related Disorders · 8
NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity
2022 · C. Alcalá, L. Cubas, et al. · Journal of Neurology · 8
Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype
2019 · Laura Navarro Cantó, Sara Carratalá Boscá, et al. · Frontiers in Neurology · 8
PDF
Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
2018 · Sara Gil-Perotin, Jéssica Castillo-Villalba, et al. · Frontiers in Neurology · 8
PDF
Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels
2024 · Carlos Quintanilla-Bordás, Laura Cubas-Núñez, et al. · Frontiers in Neurology · 7
PDF
Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
2022 · Carmen Alcalá Vicente, Laura Lacruz, et al. · Frontiers in Neurology · 6
PDF
Oligoclonal M bands unveil occult inflammation in multiple sclerosis
2022 · Bonaventura Casanova, Jessica Castillo, et al. · Multiple Sclerosis and Related Disorders · 6
Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays
2025 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Frontiers in Neurology · 5
PDF
In situ RT-PCR Optimized for Electron Microscopy Allows Description of Subcellular Morphology of Target mRNA-Expressing Cells in the Brain
2017 · Laura Cubas-Nuñez, María Duran-Moreno, et al. · Frontiers in Cellular Neuroscience · 5
PDF
Clinical Heterogeneity and Candidate Biomarkers in POLG -Related Mitochondrial Disease
2026 · Laura Bermejo-Guerrero, Juan Luis Restrepo-Vera, et al. · Neurology Genetics · 4
PDF
Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report
2024 · Carlos Quintanilla-Bordás, David Gorriz, et al. · Frontiers in Immunology · 4
PDF
Comparative Assessment of Simoa and Lumipulse for Measuring Serum Neurofilament Light Chain in Multiple Sclerosis Patients
2024 · Raquel Gasque-Rubio, Laura Cubas-Nuñez, et al. · Acta Neurologica Scandinavica · 4
PDF
Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study
2024 · Carlos Quintanilla-Bordás, Matías Fernández-Patón, et al. · Neurological Sciences · 2
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?
2024 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Journal of Neuroimmunology · 2
Development and optimisation of an animal model for the study of ganglion cells in degenerative diseases of the retina and optic nerve
2019 · A. Feliciano-Sanchez, R. García-Gil, et al. · Archivos de la Sociedad Española de Oftalmología (English Edition) · 2
Tear CHI3L1 in multiple sclerosis: a non-invasive biomarker linked to disease progression
2026 · Jéssica Castillo-Villalba, Raquel Gasque-Rubio, et al. · Multiple Sclerosis and Related Disorders · 1
Works count: 35
Citation count: 371
H-index: 8
I10-index: 8
Year
Topic
Type